Marathon Petroleum stock rating downgraded by Raymond James despite price target increase

Raymond James downgraded Marathon Petroleum (MPC) from Strong Buy to Outperform, citing the stock's significant 27.34% year-to-date gain and current valuation which has largely priced in its positive performance. Despite the downgrade, the firm raised its price target to $200, indicating continued confidence in MPC's fundamentals and strategic execution, including its consistent dividend growth. Other analysts have also adjusted ratings, with Wolfe Research downgrading to Peerperform due to valuation, while MPC reported mixed Q1 2025 results (EPS miss, revenue beat) and continues strategic investments.

Analysis

Marathon Petroleum (MPC) is facing a re-evaluation from analysts due to its significant stock appreciation, with shares gaining 27.34% year-to-date and trading near their 52-week high. The prevailing sentiment, exemplified by Raymond James's downgrade from Strong Buy to Outperform, is that the company's strong execution and shareholder return strategy are now largely priced into the stock. Despite the downgrade, Raymond James raised its price target to $200, signaling continued confidence in MPC's fundamentals, which are supported by 15 consecutive years of dividend payments and recent 10.3% dividend growth. This view is echoed by other firms; Wolfe Research downgraded MPC to Peerperform and Evercore ISI initiated coverage with an In Line rating, both citing valuation. The company's recent financial performance presents a mixed picture, with a Q1 2025 net loss of $0.24 per share missing estimates, while revenue of $31.85 billion slightly exceeded forecasts. MPC's strategic focus remains on its $1.25 billion capital plan for 2025, aimed at driving growth in its MPLX segment.

Key Decisions for Investors

• Given the consensus among analysts that the stock is approaching fair value after a 27.34% year-to-date run, investors holding substantial gains may consider trimming their positions to realize profits.
• Potential new investors should exercise caution, as multiple valuation-based downgrades suggest limited near-term upside; waiting for a pullback could offer a more attractive entry point.
• Investors should monitor upcoming quarterly results for a turnaround from the Q1 EPS miss and for tangible progress on the $1.25 billion capital plan, as strong fundamental execution is now critical to support the current valuation.
• For income-focused portfolios, the consistent dividend with 10.3% recent growth remains a positive attribute, but this should be weighed against the risk of capital appreciation stagnating in the near term.